Why the study?
The prevalence of congenital long QT syndrome based on genetic and ECG data is known, but the prevalence of electrocardiographically determined prolonged corrected QT interval in infants remains unclear.
What is the prevalence of prolonged QTc in 1-month-old infants, and what is the optimal QTc cutoff value for screening?
What is the prevalence of prolonged QTc in 1-month-old infants, and what is the optimal QTc cutoff value for screening?
ECG screening of 1-month-old infants reveals a prolonged QTc prevalence of approximately 1:1,000, with a QTc(B) ≥0.45 being an optimal screening cutoff.
May inform infant QTc screening thresholds; leaves open outcome impact on sudden death prevention.
BACKGROUND: The prevalence of congenital long QT syndrome (LQTS) (1 : 2,000) is based on genetic testing and ECG data, but the prevalence of electrocardiographically determined prolonged corrected QT interval (pQTc) in infants is unclear. METHODS AND RESULTS: Subjects were 10,282 1-month-old infants who participated in 2 prospective ECG screening studies performed in 2010-2011 and 2014-2016. Infants with a QTc ≥0.45 using Bazett's formula [QTc(B)] at 1-month medical checks were re-examined. pQTc was defined as QTc ≥0.46 on 2 different ECGs in early infancy. Infants with QTc ≥0.50 or progressive prolongation of QTc to 0.50 were defined as at high risk. The prevalence of infants with a pQTc was 11/10,282 (1 : 935; 95% confidence interval, 1 : 588-1 : 2,283). Five infants were diagnosed as at high risk, and all infants had an abrupt increase in QTc(B) values in early infancy, mostly at 6-11 weeks after birth and when medication was started. No infants with a pQTc experienced LQTS-related symptoms. Statistical analysis showed that a cutoff QTc(B) ≥0.45 was optimal for screening infants with a pQTc. CONCLUSIONS: The prevalence of ECG-determined pQTc is approximately 1 : 1,000. An abrupt increase in QTc(B) values occurs in infants at high risk, mostly at 6-11 weeks after birth. A cutoff QTc(B) value ≥0.45 may be appropriate for 1-month-old screening in this population.
No takes yet. Share an insight, caveat, or question.
Yoshinaga et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: